R

RTW Investments

Lifecycle-focused life sciences investor

Vice President – New Ventures - Asset Selection

Venture CapitalConfirmed live in the last 24 hours
Full-timeNew York, NY, USA

About the Job

Requirements

  • A bachelor's degree in biological sciences and a strong understanding of biological sciences are required.
  • At least 5 years of experience focused on the biotech or pharmaceutical sector is required.
  • Applicants should be able to operate independently on strategic and tactical tasks and clearly articulate their process.
  • Applicants should have an investor mindset and deep experience producing research notes.
  • Applicants must be based in New York and willing to travel 15%.
  • Applicants should have excellent written and verbal communication skills.
  • Applicants should demonstrate tenacity in conducting detailed research and presenting findings.

Responsibilities

  • Source and maintain a pipeline of novel drug development ideas for NewCos within assigned therapeutic areas.
  • Conduct proprietary research to analyze assets across science, disease, commercial, intellectual property, chemistry, manufacturing and controls, clinical development, regulatory, and valuation areas.
  • Write, pitch, and maintain investment notes for company ideas.
  • Build pitch decks that include recommended deal terms, clinical development, and financing.
  • Develop expertise within assigned therapeutic areas.
  • Attend relevant medical, banking, and partnering conferences.
  • Convert ideas into NewCos with successful profit and loss.

Desired Qualifications

  • An advanced degree, specifically an MD or PhD, is strongly preferred.
  • Buy-side experience is preferred.
  • Applicants with MD or PhD degrees and fewer than 5 years of experience who are looking to change careers are also considered.
  • Relevant academic or industry experience in life sciences is preferred.

About the Company

RTW Investments

Lifecycle-focused life sciences investor

RTW Investments, LP is a global life sciences investment firm that guides assets through the full investment lifecycle, from early research and company creation to venture and public-market investing. Its approach centers on science-led analysis to identify biopharmaceutical and medical technology assets with high growth potential and then allocates capital across stages, earning fees and performance-based rewards. The firm differentiates itself by combining early-stage company creation with later-stage and public-market investing, enabling long-term partnerships and deeper involvement across the company’s growth, with a global footprint in New York, London, and Shanghai. Its goal is to bring transformative therapies and medical technologies to commercialization, improving patient outcomes while delivering returns for its funds.

Company size
Not listed
Company stage
Not listed
Total funding
$14.1B
Headquarters
New York City, New York
Founded
2010

Recently Posted Jobs

Explore more opportunities at RTW Investments

See more jobs